Author:
Abbas Miri Zahra Sadat,Takhti Nazanin Zahra,Hassaneini Fatemeh Sadat,Kavehbakhshayesh Kiana
Abstract
Cancer is known as an incurable, deadly and deadly disease with pain and disability. During recent decades, changes in people's lifestyles have increased the incidence and prevalence of breast cancer worldwide. With the wide spread of this disease, research has also increased on this issue. Resveratrol is known as a natural polyphenol found in red grapes and some other foods, and with its important anti-cancer properties, it can be effective in reducing the risk of breast cancer and its treatment. Research has shown that resveratrol can have positive effects on breast cancer by reducing DNA methylation, reducing cell proliferation, and reducing cancer growth factors. In this research, resveratrol has been used against 4T1 cancer cells, which were treated with different concentrations of resveratrol after cultivation in 96-well plates and measured by the MTT method. The obtained results showed that resveratrol in all concentrations and at different times significantly reduces the survival of 4T1 cancer cells. By increasing the concentration and treatment time, the decrease in cell viability increases. This indicates strong, dose- and time-dependent effects of resveratrol on breast cancer cells.
Reference18 articles.
1. Lima, S.M., R.D. Kehm, and M.B. Terry, Global breast cancer incidence and mortality trends by region, age groups, and fertility patterns. EClinicalMedicine, 2021. 38.
2. Lei, S., et al., Global patterns of breast cancer incidence and mortality: A population‐based cancer registry data analysis from 2000 to 2020. Cancer Communications, 2021. 41(11): p. 1183-1194.
3. Franceschi, B. and M.R. Torqueti, Evaluation of the effect of resveratrol isolated and in combination with tamoxifen on the viability of breast cancer cells. Journal of International Society of Antioxidants in Nutrition & Health, 2016. 3(4).
4. Stepanenko, A. and V. Dmitrenko, Pitfalls of the MTT assay: Direct and off-target effects of inhibitors can result in over/underestimation of cell viability. Gene, 2015. 574(2): p. 193-203.
5. Jin, X., et al., Resveratrol promotes sensitization to Doxorubicin by inhibiting epithelial‐mesenchymal transition and modulating SIRT1/β‐catenin signalling pathway in breast cancer. Cancer medicine, 2019. 8(3): p. 1246-1257.